| Literature DB >> 27704039 |
Åsa Thelaus1, Tobias Pettersson2, Max Gordon1, Ferid Krupic3, Olof Sköldenberg1.
Abstract
We investigated if a femoral nerve block (FNB) for patients with a proximal femoral fracture (PFF) and administered by an orthopaedic registrar (OR) instead of an anaesthesiology registrar (AR) lowers the lead time to block and reduces the total amount of rescue analgesics during the preoperative phase. 205 patients were included in a prospective observational cohort study. The main outcome variable was rescue analgesics as total intravenous morphine prior to surgery. All results were adjusted for confounding using age, sex, cognitive dysfunction, and ASA classification. The OR group (n = 135) was over 2 hours faster in performing the block compared to the AR group (n = 70) but was nonetheless correlated with an increased amount of rescue analgesics during the study, 2.4 mg morphine (95% CI 0.0-4.9) more compared to the AR group. We found no difference between the groups in the risk of adverse events. We conclude that, for patients with an acute PFF and with morphine consumption as end point, how soon from arrival to hospital the patients receive a FNB is of lesser importance than who is administering it. Based on our results we recommend that emergency hospitals should have routines for anaesthesiologists performing FNB on this frail patient group.Entities:
Year: 2016 PMID: 27704039 PMCID: PMC5040792 DOI: 10.1155/2016/7512360
Source DB: PubMed Journal: Surg Res Pract ISSN: 2356-6124
Characteristics of the patients and main outcomes.
| AR group ( | OR group ( | |
|---|---|---|
|
| ||
| Age (years)1 | 82 (10) | 83 (9) |
| Sex2 | ||
| Female | 57 (81%) | 96 (71%) |
| Male | 13 (19%) | 39 (29%) |
| Weight (kg)2 | 63 (13) | 66 (13) |
| ASA classification2 | ||
| 1-2 | 19 (27%) | 43 (32%) |
| 3-4 | 51 (73%) | 92 (68%) |
| Cognitive dysfunction2 | ||
| No | 47 (67%) | 85 (63%) |
| Yes | 23 (33%) | 50 (37%) |
| Type of fracture2 | ||
| Femoral neck | 35 (50%) | 61 (45%) |
| Trochanteric | 31 (44%) | 63 (47%) |
| Subtrochanteric | 4 (6%) | 11 (8%) |
|
| ||
| Total morphine consumption (mg)1 | 11.7 (8.8) | 13.6 (8.5) |
| Adverse events2 | ||
| No | 50 (71%) | 105 (78%) |
| Yes | 20 (29%) | 30 (22%) |
| Time from arrival to FNB (h)1 | 5.3 (3.0) | 3.0 (1.9) |
| Morphine consumption before FNB (mg)1 | 9.0 (7.9) | 9.5 (6.5) |
| Morphine consumption after FNB (mg)1 | 2.7 (3.9) | 4.1 (5.0) |
1Mean (SD)
2 n (%).
Linear and logistic regression analyses with crude and adjusted outcomes. Potential confounders adjusted for are age, sex, ASA class, and cognitive dysfunction. Only the exposure variable (group) and confounders with p values ≤ 0.05 are presented.
| Crude | Adjusted | |||
|---|---|---|---|---|
| Est. | 95% CI | Est. | 95% CI | |
|
| ||||
|
| ||||
| OR group | 1.9 | −0.6–4.4 | 2.4 | 0.0–4.9 |
| Age | −0.3 | −0.4–−0.2 | −0.3 | −0.4–−0.1 |
| Cognitive dysfunction | −3.8 | −6.2–−1.3 | −2.8 | −5.3–−0.2 |
|
| ||||
| OR group | −2.2 | −2.9–−1.5 | −2.2 | −2.9–−1.6 |
| ASA 3-4 | 0.5 | −0.3–1.3 | 0.3 | −0.5–1.0 |
|
| ||||
|
| ||||
|
| ||||
| OR group | 0.7 | 0.4–1.4 | 0.8 | 0.4–1.5 |
| Male sex | 0.3 | 0.1–0.7 | 0.3 | 0.1–0.8 |